Beyond The Numbers: 7 Analysts Discuss Capricor Therapeutics Stock
Beyond The Numbers: 7 Analysts Discuss Capricor Therapeutics Stock
超越數字：7位分析師討論Capricor Therapeutics股票
A comprehensive examination of how...Ratings for Capricor Therapeutics (NASDAQ:CAPR) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去三個月中，7位分析師對Capricor Therapeutics（納斯達克：CAPR）的評級展示了看好和看淡的觀點組合。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
總結他們最近的評估，下面的表格顯示了過去30天裏情緒的變化，並將其與之前的月份進行了比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $53.71, a high estimate of $77.00, and a low estimate of $30.00. This upward trend is evident, with the current average reflecting a 3.69% increase from the previous average price target of $51.80.
分析師通過對12個月價格目標的評估提供更深入的見解，顯示出平均目標爲53.71美元，高估計爲77.00美元，低估計爲30.00美元。這一上升趨勢顯而易見，目前的平均值反映出比之前的平均價格目標51.80美元增長了3.69%。
Decoding Analyst Ratings: A Detailed Look
Decoding Analyst Ratings: A Detailed Look
A comprehensive examination of how...
對財務專家...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。